Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study
- PMID: 8071601
Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study
Abstract
Plasma low density lipoprotein (LDL) cholesterol, non-high density lipoprotein (HDL) cholesterol, and apolipoprotein (apo) B, the major protein constituent of LDL, were measured in 1,533 men (mean age 49 +/- 10 years) and 1,597 women (mean age 49 +/- 10 years) participating in the 3rd examination cycle of the Framingham Offspring Study. Mean plasma levels of LDL cholesterol and apoB were higher in men than in women (136 versus 132 mg/dl, P < 0.0001; and 109 versus 95 mg/dl, P < 0.0001, respectively). Increased age was associated with higher plasma LDL cholesterol and apoB levels, especially in women. After adjustment for age and body mass index, LDL cholesterol and apoB levels were still significantly higher in postmenopausal than in premenopausal women, indicating a hormonal effect on LDL metabolism. The associations between coronary heart disease (CHD) and LDL cholesterol, non-HDL cholesterol, apoB, and other plasma lipid and lipoprotein parameters were examined by dividing participants in four groups, based on approximate quartiles for these parameters. Elevated LDL cholesterol levels were not significantly associated with CHD in men, but were in women. This result, at variance with that of several longitudinal studies, is likely due to the cross-sectional design of our analysis. Elevated non-HDL cholesterol and apoB levels were significantly associated with the presence of CHD, in both males and females. A plasma apoB value > or = 125 mg/dl may be associated with an increased risk for CHD. Low plasma levels of HDL cholesterol were also significantly associated with CHD. Plasma triglyceride levels, age and body mass index were strong determinants of LDL cholesterol, non-HDL cholesterol, and apoB levels in men and women. In women, postmenopausal status and elevated blood pressure were also significantly associated with elevated levels of these parameters.
Similar articles
-
Plasma lipoprotein and apolipoprotein levels in Taipei and Framingham.Arterioscler Thromb. 1993 Oct;13(10):1429-40. doi: 10.1161/01.atv.13.10.1429. Arterioscler Thromb. 1993. PMID: 8399079
-
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.Circulation. 2005 Nov 29;112(22):3375-83. doi: 10.1161/CIRCULATIONAHA.104.532499. Circulation. 2005. PMID: 16316964
-
Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.J Lipid Res. 1994 May;35(5):871-82. J Lipid Res. 1994. PMID: 8071609 Clinical Trial.
-
Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics.Biol Res Nurs. 2013 Jul;15(3):292-308. doi: 10.1177/1099800412436967. Epub 2012 Apr 23. Biol Res Nurs. 2013. PMID: 22531366 Free PMC article. Review.
-
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.J Am Heart Assoc. 2023 Aug;12(15):e030405. doi: 10.1161/JAHA.123.030405. Epub 2023 Jul 25. J Am Heart Assoc. 2023. PMID: 37489721 Free PMC article. Review.
Cited by
-
Association among age, gender, menopausal status and small dense low-density lipoprotein cholesterol: a cross-sectional study.BMJ Open. 2021 Feb 4;11(2):e041613. doi: 10.1136/bmjopen-2020-041613. BMJ Open. 2021. PMID: 33542041 Free PMC article.
-
Effects of statins on skeletal muscle: a perspective for physical therapists.Phys Ther. 2010 Oct;90(10):1530-42. doi: 10.2522/ptj.20090251. Epub 2010 Aug 5. Phys Ther. 2010. PMID: 20688875 Free PMC article. Review.
-
Drug Therapy of Dyslipidemia in the Elderly.Drugs Aging. 2019 Apr;36(4):321-340. doi: 10.1007/s40266-018-00632-x. Drugs Aging. 2019. PMID: 30613912 Review.
-
Factors associated with non-participation and drop-out in a lifestyle intervention for workers with an elevated risk of cardiovascular disease.Int J Behav Nutr Phys Act. 2009 Dec 1;6:80. doi: 10.1186/1479-5868-6-80. Int J Behav Nutr Phys Act. 2009. PMID: 19951417 Free PMC article.
-
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.Vasc Health Risk Manag. 2014 Feb 27;10:89-100. doi: 10.2147/VHRM.S57116. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24600231 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous